Effects of ketogenic diet on weight loss parameters among obese or overweight patients with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trails

Nan-nan Xing; Fang  Ren; Hui  Yang

doi:10.29219/fnr.v68.9835

Nan-nan Xing Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang 110022, China
Fang Ren Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang 110022, China
Hui Yang Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang 110022, China

DOI: https://doi.org/10.29219/fnr.v68.9835

Keywords: Ketogenic diet, Weight loss, Obesity, Polycystic ovary syndrome, Meta-analysis

Abstract

Aim: To evaluate how effective a low carbohydrate ketogenic diet (KD) is for changing key physical measurements such as weight, waist circumference (WC), body mass index (BMI), and fat mass (FM) in women with polycystic ovary syndrome (PCOS) who were obese or overweight.

Methods: Several online databases, including PubMed, Scopus, EMBASE, Cochrane Library, and Web of Science (WOS), were searched systematically to find relevant randomized controlled trials (RCTs) up until June 2023. The Q-test and I² statistics were used to assess the level of heterogeneity among the included studies. The data were then combined using either a fixed or random effects model and presented as a weighted mean difference (WMD) along with a 95% confidence interval (CI).

Results: Of the 682 citations, 11 RCTs were included. The pooled results showed a significant decrease in the WMD of weight levels [WMD = −9.13 kg; 95% CI, −11.88, −6.39, P < 0.001; I² = 87.23%] following KD. Moreover, KD significantly reduced BMI levels [WMD = −2.93 kg/m²; 95% CI, −3.65, −2.21, P < 0.001; I² = 78.81%] compared to the controls. Patients with PCOS received KD demonstrated significant decrease in WC [WMD = −7.62 cm; 95% CI, −10.73, −4.50, P < 0.001; I² = 89.17%] and FM [WMD = −5.32 kg; 95% CI, −7.29, −3.36, P < 0.001; I² = 83.97%].

Conclusion: KD was associated with lower weight loss (WL) parameters, including weight, BMI, WC, and FM, in obese or overweight women with PCOS, highlighting the significance of physicians and nurses in taking care of the nutritional needs of overweight/obese patients with PCOS.

Downloads

Download data is not yet available.

References

1.
Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Prim 2016; 2(1): 1–18. doi: 10.1038/nrdp.2016.57

2.
Azziz R. Polycystic ovary syndrome. Obstetr Gynecol 2018; 132(2): 321–36. doi: 10.1097/AOG.0000000000002698

3.
Yau TT, Ng NY, Cheung L, Ma RC. Polycystic ovary syndrome: a common reproductive syndrome with long-term metabolic consequences. Hong Kong Med J 2017; 23(6): 622. doi: 10.12809/hkmj176308

4.
Kakoly N, Khomami M, Joham A, Cooray S, Misso M, Norman R, et al. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Hum Reprod Update 2018; 24(4): 455–67. doi: 10.1093/humupd/dmy007

5.
Lim SS, Hutchison SK, Van Ryswyk E, Norman RJ, Teede HJ, Moran LJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2019; 3: CD007506. doi: 10.1002/14651858.CD007506.pub4

6.
Saadati N, Haidari F, Barati M, Nikbakht R, Mirmomeni G, Rahim F. The effect of low glycemic index diet on the reproductive and clinical profile in women with polycystic ovarian syndrome: a systematic review and meta-analysis. Heliyon 2021; 7(11): e08338. doi: 10.1016/j.heliyon.2021.e08338

7.
Joshi S, Ostfeld RJ, McMacken M. The ketogenic diet for obesity and diabetes – enthusiasm outpaces evidence. JAMA Intern Med 2019; 179(9): 1163–4. doi: 10.1001/jamainternmed.2019.2633

8.
Che X, Chen Z, Liu M, Mo Z. Dietary interventions: a promising treatment for polycystic ovary syndrome. Ann Nutr Metabol 2021; 77(6): 313–23. doi: 10.1159/000519302

9.
Barrea L, Verde L, Camajani E, Cernea S, Frias-Toral E, Lamabadusuriya D, et al. Ketogenic diet as medical prescription in women with polycystic ovary syndrome (PCOS). Curr Nutr Rep 2023; 12(1): 56–64. doi: 10.1007/s13668-023-00456-1

10.
Gupta L, Khandelwal D, Kalra S, Gupta P, Dutta D, Aggarwal S. Ketogenic diet in endocrine disorders: current perspectives. J Postgrad Med 2017; 63(4): 242. doi: 10.4103/jpgm.JPGM_16_17

11.
Draznin B, Wang C, Adochio R, Leitner J, Cornier M-A. Effect of dietary macronutrient composition on AMPK and SIRT1 expression and activity in human skeletal muscle. Hormone Metabol Res 2012; 44(09): 650–5. doi: 10.1055/s-0032-1312656

12.
Paoli A, Mancin L, Giacona MC, Bianco A, Caprio M. Effects of a ketogenic diet in overweight women with polycystic ovary syndrome. J Transl Med 2020; 18(1): 1–11. doi: 10.1186/s12967-020-02277-0

13.
Ruderman N, Julia Xu X, Nelson L, Cacicedo J, Saha A, Lan F, et al. AMPK 615 and SIRT1: a long-standing partnership. Am J Physiol Endocrinol Metab 2010; 298(4): E751–60. doi: 10.1152/ajpendo.00745.2009

14.
Abdolahian S, Tehrani FR, Amiri M, Ghodsi D, Yarandi RB, Jafari M, et al. Effect of lifestyle modifications on anthropometric, clinical, and biochemical parameters in adolescent girls with polycystic ovary syndrome: a systematic review and meta-analysis. BMC Endocrine Disord 2020; 20(1): 1–17. doi: 10.1186/s12902-020-00552-1

15.
Akbari M, Ostadmohammadi V, Lankarani KB, Tabrizi R, Kolahdooz F, Heydari ST, et al. The effects of vitamin D supplementation on biomarkers of inflammation and oxidative stress among women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Hormone Metabol Res 2018; 50(04): 271–9. doi: 10.1055/s-0044-101355

16.
Heydarpour F, Hemati N, Hadi A, Moradi S, Mohammadi E, Farzaei MH. Effects of cinnamon on controlling metabolic parameters of polycystic ovary syndrome: a systematic review and meta-analysis. J Ethnopharmacol 2020; 254: 112741. doi: 10.1016/j.jep.2020.112741

17.
Azadi-Yazdi M, Nadjarzadeh A, Khosravi-Boroujeni H, Salehi-Abargouei A. The effect of vitamin D supplementation on the androgenic profile in patients with polycystic ovary syndrome: a systematic review and meta-analysis of clinical trials. Hormone Metabol Res 2017; 49(03): 174–9. doi: 10.1055/s-0043-103573

18.
Carmina E, Azziz R, Bergfeld W, Escobar-Morreale HF, Futterweit W, Huddleston H, et al. Female pattern hair loss and androgen excess: a report from the multidisciplinary androgen excess and PCOS committee. J Clin Endocrinol Metabol 2019; 104(7): 2875–91. doi: 10.1210/jc.2018-02548

19.
Heshmati J, Omani-Samani R, Vesali S, Maroufizadeh S, Rezaeinejad M, Razavi M, et al. The effects of supplementation with chromium on insulin resistance indices in women with polycystic ovarian syndrome: a systematic review and meta-analysis of randomized clinical trials. Hormone Metabol Res 2018; 50(03): 193–200. doi: 10.1055/s-0044-101835

20.
Łagowska K, Bajerska J, Jamka M. The role of vitamin D oral supplementation in insulin resistance in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Nutrients 2018; 10(11): 1637. doi: 10.3390/nu10111637

21.
Shang Y, Zhou H, Hu M, Feng H. Effect of diet on insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metabol 2020; 105(10): 3346–60. doi: 10.1210/clinem/dgaa425

22.
Sadeghi A, Djafarian K, Mohammadi H, Shab-Bidar S. Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: meta-analysis of randomized controlled trials. Diabetes Metabol Syndr Clin Res Rev 2017; 11(2): 157–62. doi: 10.1016/j.dsx.2016.06.025

23.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009; 151(4): W-65–W-94. doi: 10.7326/0003-4819-151-4-200908180-00136

24.
Yang M, Bai W, Jiang B, Wang Z, Wang X, Sun Y, et al. Effects of a ketogenic diet in women with PCOS with different uric acid concentrations: a prospective cohort study. Reprod BioMed Online 2022; 45(2): 391–400. doi: 10.1016/j.rbmo.2022.03.023

25.
Li J, Bai WP, Jiang B, Bai LR, Gu B, Yan SX, et al. Ketogenic diet in women with polycystic ovary syndrome and liver dysfunction who are obese: a randomized, open-label, parallel-group, controlled pilot trial. J Obstetr Gynaecol Res 2021; 47(3): 1145–52. doi: 10.1111/jog.14650

26.
Avolio E, Ferraro S, Mocciaro R, De Pergola G, Buzzanca F, Venturella R, et al. The effect of ketogenic and low carb diet (Cyclic Alternation) on the ovarian morphology and insulin metabolism in polycystic ovary syndrome patients. Clin Obstet Gynecol 2020; 6: 1–6. doi: 10.15761/COGRM.1000307

27.
Cincione RI, Losavio F, Ciolli F, Valenzano A, Cibelli G, Messina G, et al. Effects of mixed of a ketogenic diet in overweight and obese women with polycystic ovary syndrome. Int J Environ Res Public Health 2021; 18(23): 12490. doi: 10.3390/ijerph182312490

28.
Cincione I, Graziadio C, Marino F, Vetrani C, Losavio F, Savastano S, et al. Short-time effects of ketogenic diet or modestly hypocaloric Mediterranean diet on overweight and obese women with polycystic ovary syndrome. J Endocrinol Investig 2023; 46(4): 769–77. doi: 10.1007/s40618-022-01943-y

29.
Mavropoulos JC, Yancy WS, Hepburn J, Westman EC. The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: a pilot study. Nutr Metabol 2005; 2(1): 1–5. doi: 10.1186/1743-7075-2-35

30.
Liran B, Jian L, Litian N, Aili W, Fengyun W, Wenpei B, et al. Preliminary report of a single-center clinical study for ketogenic diet intervention of polycystic ovary syndrome. 实用临床医药杂志. 2019; 23(7): 2–5.

31.
Jian L, Wenpei B, Bo J, Feiran L, Yanrong C. Effects of ketogenic diet on vitamin D and glycolipid metabolism in overweight or obese patients with polycystic ovary syndrome. 实用临床医药杂志. 2022; 26(4): 14–17.

32.
Pandurevic S, Mancini I, Mitselman D, Magagnoli M, Teglia R, Fazzeri R, et al. Efficacy of very low-calorie ketogenic diet with the Pronokal® method in obese women with polycystic ovary syndrome: a 16-week randomized controlled trial. Endocrine Connect 2023; 12(7): e220536. doi: 10.1530/EC-22-0536

33.
Magagnini MC, Condorelli RA, Cimino L, Cannarella R, Aversa A, Calogero AE, et al. Does the ketogenic diet improve the quality of ovarian function in obese women? Nutrients 2022; 14(19): 4147. doi: 10.3390/nu14194147

34.
Basciani S, Camajani E, Contini S, Persichetti A, Risi R, Bertoldi L, et al. Very-low-calorie ketogenic diets with whey, vegetable, or animal protein in patients with obesity: a randomized pilot study. J Clin Endocrinol Metabol 2020; 105(9): 2939–49. doi: 10.1210/clinem/dgaa336

35.
Merra G, Gratteri S, De Lorenzo A, Barrucco S, Perrone M, Avolio E, et al. Effects of very-low-calorie diet on body composition, metabolic state, and genes expression: a randomized double-blind placebo-controlled trial. Eur Rev Med Pharmacol Sci 2017; 21(2): 329–45.

36.
Saslow LR, Daubenmier JJ, Moskowitz JT, Kim S, Murphy EJ, Phinney SD, et al. Twelve-month outcomes of a randomized trial of a moderate-carbohydrate versus very low-carbohydrate diet in overweight adults with type 2 diabetes mellitus or prediabetes. Nutr Diabetes 2017; 7(12): 304. doi: 10.1038/s41387-017-0006-9

37.
Cunha GM, Guzman G, Correa De Mello LL, Trein B, Spina L, Bussade I, et al. Efficacy of a 2-month very low-calorie ketogenic diet (VLCKD) compared to a standard low-calorie diet in reducing visceral and liver fat accumulation in patients with obesity. Front Endocrinol 2020; 11: 607. doi: 10.3389/fendo.2020.00607

38.
Zhao H, Jin H, Xian J, Zhang Z, Shi J, Bai X. Effect of ketogenic diets on body composition and metabolic parameters of cancer patients: a systematic review and meta-analysis. Nutrients 2022; 14(19): 4192. doi: 10.3390/nu14194192

39.
Vargas S, Romance R, Petro JL, Bonilla DA, Galancho I, Espinar S, et al. Efficacy of ketogenic diet on body composition during resistance training in trained men: a randomized controlled trial. J Int Soc Sports Nutr 2018; 15(1): 31. doi: 10.1186/s12970-018-0236-9

40.
Gomez-Arbelaez D, Bellido D, Castro AI, Ordoñez-Mayan L, Carreira J, Galban C, et al. Body composition changes after very-low-calorie ketogenic diet in obesity evaluated by 3 standardized methods. J Clin Endocrinol Metabol 2017; 102(2): 488–98. doi: 10.1210/jc.2016-2385

41.
Luo W, Zhang J, Xu D, Zhou Y, Qu Z, Yang Q, et al. Low carbohydrate ketogenic diets reduce cardiovascular risk factor levels in obese or overweight patients with T2DM: a meta-analysis of randomized controlled trials. Front Nutr 2022; 9: 1092031. doi: 10.3389/fnut.2022.1092031

42.
Ibáñez L, de Zegher F. Adolescent PCOS: a postpubertal central obesity syndrome. Trends Mol Med 2023; 29(5): 354–363. doi: 10.1016/j.molmed.2023.02.006

43.
Orio F, Muscogiuri G, Nese C, Palomba S, Savastano S, Tafuri D, et al. Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome. Eur J Obstetr Gynecol Reprod Biol 2016; 207: 214–9. doi: 10.1016/j.ejogrb.2016.08.026

44.
Teede HJ, Misso ML, Deeks AA, Moran LJ, Stuckey BG, Wong JL, et al. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust 2011; 195(6): S65. doi: 10.5694/mja11.10915

45.
Park Y-M, Zhang J, Steck SE, Fung TT, Hazlett LJ, Han K, et al. Obesity mediates the association between Mediterranean diet consumption and insulin resistance and inflammation in US adults. J Nutr 2017; 147(4): 563–571. doi: 10.3945/jn.116.243543

46.
Zhang X, Zheng Y, Guo Y, Lai Z. The effect of low carbohydrate diet on polycystic ovary syndrome: a meta-analysis of randomized controlled trials. Int J Endocrinol 2019; 2019: 4386401. doi: 10.1155/2019/4386401

47.
Teede H, Misso M, Costello M, Dokras A, Laven J, Moran L, et al. International PCOS Network. Recommendations from the international evidence-based guideline others Well-being and personality in PCOS for the assessment and management of polycystic ovary syndrome. Fertil Steril 2018; 110: 364–79. doi: 10.1016/j.fertnstert.2018.05.004

48.
Lin AW, Dollahite JS, Sobal J, Lujan ME. Health-related knowledge, beliefs and self-efficacy in women with polycystic ovary syndrome. Hum Reprod 2018; 33(1): 91–100. doi: 10.1093/humrep/dex351

49.
Kozica SL, Gibson-Helm ME, Teede HJ, Moran LJ. Assessing self-efficacy and self-help methods in women with and without polycystic ovary syndrome. Behav Med 2013; 39(3): 90–6. doi: 10.1080/08964289.2012.720312

50.
Ye W, Xie T, Song Y, Zhou L. The role of androgen and its related signals in PCOS. J Cell Mol Med 2021; 25(4): 1825–37. doi: 10.1111/jcmm.16205

51.
Karpe F, Pinnick KE. Biology of upper-body and lower-body adipose tissue – link to whole-body phenotypes. Nat Rev Endocrinol 2015; 11(2): 90–100. doi: 10.1038/nrendo.2014.185

52.
Kim JY, Tfayli H, Michaliszyn SF, Arslanian S. Impaired lipolysis, diminished fat oxidation, and metabolic inflexibility in obese girls with polycystic ovary syndrome. J Clin Endocrinol Metabol 2018; 103(2): 546–54. doi: 10.1210/jc.2017-01958

53.
Di Sarra D, Tosi F, Bonin C, Fiers T, Kaufman J-M, Signori C, et al. Metabolic inflexibility is a feature of women with polycystic ovary syndrome and is associated with both insulin resistance and hyperandrogenism. J Clin Endocrinol Metabol 2013; 98(6): 2581–8. doi: 10.1210/jc.2013-1161

54.
Colica C, Merra G, Gasbarrini A, De Lorenzo A, Cioccoloni G, Gualtieri P, et al. Efficacy and safety of very-low-calorie ketogenic diet: a double blind randomized crossover study. Eur Rev Med Pharmacol Sci 2017; 21(9): 2274–89.

55.
Marchetti M, Gualtieri P, Romano L, Merra G. What is the importance of saving lean mass in the treatment of obesity and related diseases? Eur Rev Med Pharmacol Sci 2019; 23(2): 431–2.

56.
Colica C, Di Renzo L, Trombetta D, Smeriglio A, Bernardini S, Cioccoloni G, et al. Antioxidant effects of a hydroxytyrosol-based pharmaceutical formulation on body composition, metabolic state, and gene expression: a randomized double-blinded, placebo-controlled crossover trial. Oxidat Med Cell Longevity 2017; 2017: 2473495. doi: 10.1155/2017/2473495